Compare $CLDX vs $IMNM | Chartloom

Compare

$CLDX vs $IMNM

Celldex Therapeutics Inc · Immunome Inc

CLDX

Celldex Therapeutics Inc

IMNM

Immunome Inc

Compare $CLDX vs $IMNM

Comparing Celldex Therapeutics Inc and Immunome Inc

CLDXCelldex Therapeutics Inc

IMNMImmunome Inc

CLDXCelldex Therapeutics Inc

Market cap

$2.35B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1,016.81x

Rev growth (TTM)

-97.3%

YTD performance

10.7%

52W performance

9.7%

FCF yield

-10.3%

IMNMImmunome Inc

Market cap

$2.21B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

127.50x

Rev growth (TTM)

-100.0%

YTD performance

-6.1%

52W performance

39.5%

FCF yield

-10.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLDX

IMNM

Detailed metrics comparison

CLDX

Celldex Therapeutics Inc

IMNM

Immunome Inc

Market Cap

CLDX$2.35B

IMNM$2.21B

Enterprise Value

CLDX$2.30B

IMNM$2.00B

Price

CLDX$29.89

IMNM$19.55

P/E Ratio

CLDXN/A

IMNMN/A

P/S Ratio

CLDX14,848.52x

IMNM188.56x

EV/Sales

CLDX14,548.18x

IMNM171.27x

EV/EBITDA

CLDX0.00x

IMNM0.00x

P/B Ratio

CLDX3.48x

IMNM4.52x

P/FCF Ratio

CLDXN/A

IMNMN/A

EV/FCF

CLDX-9.49x

IMNM-8.75x

PEG Ratio

CLDXN/A

IMNMN/A

Forward P/E (NTM)

CLDXN/A

IMNMN/A

Forward P/S (NTM)

CLDX1,016.81x

IMNM127.50x

Revenue (TTM)

CLDX$158K

IMNM$0

Revenue Growth (YoY)

CLDX-97.3%

IMNM-100.0%

Forward Rev Growth

CLDX637.2%

IMNM15247.2%

Gross Margin (TTM)

CLDX17.6%

IMNM0.0%

Operating Margin (TTM)

CLDX0.0%

IMNM0.0%

EBITDA Margin (TTM)

CLDX-204070.9%

IMNM0.0%

Net Margin (TTM)

CLDX-190220.9%

IMNM0.0%

FCF Margin (TTM)

CLDX-153231.0%

IMNMN/A

Net Income (TTM)

CLDX$-301M

IMNM$-254M

FCF (TTM)

CLDX$-242M

IMNM$-228M

EPS (TTM)

CLDX-$3.86

IMNM-$2.25

ROE (TTM)

CLDX-5235.0%

IMNM-5056.0%

ROA (TTM)

CLDX-4761.0%

IMNM-4693.0%

ROIC (TTM)

CLDX-5235.0%

IMNM-5056.0%

Cash

CLDX$47M

IMNM$218M

Debt

CLDX$0

IMNM$0

Net Cash/Debt

CLDX$47M

IMNM$218M

Current Ratio (TTM)

CLDX11.82x

IMNM15.08x

Quick Ratio (TTM)

CLDX11.71x

IMNM14.56x

Debt/Equity (TTM)

CLDX0.00x

IMNM0.00x

Debt/Assets (TTM)

CLDX0.0%

IMNM0.0%

Interest Coverage (TTM)

CLDXN/A

IMNMN/A

Net Debt/EBITDA (TTM)

CLDX0.00x

IMNM0.00x

Beta

CLDX0.99

IMNM2.65

52W Performance

CLDX9.7%

IMNM39.5%

YTD Performance

CLDX10.7%

IMNM-6.1%

% from 52W High

CLDX-33.8%

IMNM-35.0%

% from 52W Low

CLDX35.2%

IMNM44.9%

Asset Turnover (TTM)

CLDX0.00x

IMNM0.04x

FCF Yield (TTM)

CLDX-10.3%

IMNM-10.3%

Earnings Yield (TTM)

CLDX-12.8%

IMNM-11.5%

Dividend Yield (TTM)

CLDXN/A

IMNMN/A

Rule of 40

CLDX-153,328.3

IMNM-100.0

EV/GP/RG

CLDX42.93

IMNMN/A

Ticker research

View CLDX research View IMNM research

Metric	CLDX Celldex Therapeutics Inc	IMNM Immunome Inc
Market & Valuation
Market Cap	$2.35B	$2.21B
Enterprise Value	$2.30B	$2.00B
Price	$29.89	$19.55
P/E Ratio	N/A	N/A
P/S Ratio	14,848.52x	188.56x
EV/Sales	14,548.18x	171.27x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.48x	4.52x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.49x	-8.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1,016.81x	127.50x
Revenue & Growth
Revenue (TTM)	$158K	$0
Revenue Growth (YoY)	-97.3%	-100.0%
Forward Rev Growth	637.2%	15247.2%
Profitability
Gross Margin (TTM)	17.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-204070.9%	0.0%
Net Margin (TTM)	-190220.9%	0.0%
FCF Margin (TTM)	-153231.0%	N/A
Net Income (TTM)	$-301M	$-254M
FCF (TTM)	$-242M	$-228M
EPS (TTM)	-$3.86	-$2.25
ROE (TTM)	-5235.0%	-5056.0%
ROA (TTM)	-4761.0%	-4693.0%
ROIC (TTM)	-5235.0%	-5056.0%
Financial Health
Cash	$47M	$218M
Debt	$0	$0
Net Cash/Debt	$47M	$218M
Current Ratio (TTM)	11.82x	15.08x
Quick Ratio (TTM)	11.71x	14.56x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	2.65
52W Performance	9.7%	39.5%
YTD Performance	10.7%	-6.1%
% from 52W High	-33.8%	-35.0%
% from 52W Low	35.2%	44.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-10.3%	-10.3%
Earnings Yield (TTM)	-12.8%	-11.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-153,328.3	-100.0
EV/GP/RG	42.93	N/A
Ticker research	View CLDX research	View IMNM research

Valuation

P/S Ratio

IMNM

188.56x

CLDX

14,848.52x

EV/FCF

CLDX

-9.49x

IMNM

-8.75x

Growth & revenue

Revenue Growth TTM

CLDX

-97.3%

IMNM

-100.0%

Forward Revenue Growth

IMNM

15247.2%

CLDX

637.2%

Profitability & performance

Gross Margin

CLDX

17.6%

IMNM

0.0%

ROE

IMNM

-5056.0%

CLDX

-5235.0%

FCF Yield %

IMNM

-10.3%

CLDX

-10.3%

52-Week Performance

IMNM

39.5%

CLDX

9.7%

Detailed metrics comparison

CLDX

Celldex Therapeutics Inc

IMNM

Immunome Inc

Market Cap

CLDX$2.35B

IMNM$2.21B

Enterprise Value

CLDX$2.30B

IMNM$2.00B

Price

CLDX$29.89

IMNM$19.55

P/E Ratio

CLDXN/A

IMNMN/A

P/S Ratio

CLDX14,848.52x

IMNM188.56x

EV/Sales

CLDX14,548.18x

IMNM171.27x

EV/EBITDA

CLDX0.00x

IMNM0.00x

P/B Ratio

CLDX3.48x

IMNM4.52x

P/FCF Ratio

CLDXN/A

IMNMN/A

EV/FCF

CLDX-9.49x

IMNM-8.75x

PEG Ratio

CLDXN/A

IMNMN/A

Forward P/E (NTM)

CLDXN/A

IMNMN/A

Forward P/S (NTM)

CLDX1,016.81x

IMNM127.50x

Revenue (TTM)

CLDX$158K

IMNM$0

Revenue Growth (YoY)

CLDX-97.3%

IMNM-100.0%

Forward Rev Growth

CLDX637.2%

IMNM15247.2%

Gross Margin (TTM)

CLDX17.6%

IMNM0.0%

Operating Margin (TTM)

CLDX0.0%

IMNM0.0%

EBITDA Margin (TTM)

CLDX-204070.9%

IMNM0.0%

Net Margin (TTM)

CLDX-190220.9%

IMNM0.0%

FCF Margin (TTM)

CLDX-153231.0%

IMNMN/A

Net Income (TTM)

CLDX$-301M

IMNM$-254M

FCF (TTM)

CLDX$-242M

IMNM$-228M

EPS (TTM)

CLDX-$3.86

IMNM-$2.25

ROE (TTM)

CLDX-5235.0%

IMNM-5056.0%

ROA (TTM)

CLDX-4761.0%

IMNM-4693.0%

ROIC (TTM)

CLDX-5235.0%

IMNM-5056.0%

Cash

CLDX$47M

IMNM$218M

Debt

CLDX$0

IMNM$0

Net Cash/Debt

CLDX$47M

IMNM$218M

Current Ratio (TTM)

CLDX11.82x

IMNM15.08x

Quick Ratio (TTM)

CLDX11.71x

IMNM14.56x

Debt/Equity (TTM)

CLDX0.00x

IMNM0.00x

Debt/Assets (TTM)

CLDX0.0%

IMNM0.0%

Interest Coverage (TTM)

CLDXN/A

IMNMN/A

Net Debt/EBITDA (TTM)

CLDX0.00x

IMNM0.00x

Beta

CLDX0.99

IMNM2.65

52W Performance

CLDX9.7%

IMNM39.5%

YTD Performance

CLDX10.7%

IMNM-6.1%

% from 52W High

CLDX-33.8%

IMNM-35.0%

% from 52W Low

CLDX35.2%

IMNM44.9%

Asset Turnover (TTM)

CLDX0.00x

IMNM0.04x

FCF Yield (TTM)

CLDX-10.3%

IMNM-10.3%

Earnings Yield (TTM)

CLDX-12.8%

IMNM-11.5%

Dividend Yield (TTM)

CLDXN/A

IMNMN/A

Rule of 40

CLDX-153,328.3

IMNM-100.0

EV/GP/RG

CLDX42.93

IMNMN/A

Ticker research

View CLDX research View IMNM research

Metric	CLDX Celldex Therapeutics Inc	IMNM Immunome Inc
Market & Valuation
Market Cap	$2.35B	$2.21B
Enterprise Value	$2.30B	$2.00B
Price	$29.89	$19.55
P/E Ratio	N/A	N/A
P/S Ratio	14,848.52x	188.56x
EV/Sales	14,548.18x	171.27x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.48x	4.52x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.49x	-8.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1,016.81x	127.50x
Revenue & Growth
Revenue (TTM)	$158K	$0
Revenue Growth (YoY)	-97.3%	-100.0%
Forward Rev Growth	637.2%	15247.2%
Profitability
Gross Margin (TTM)	17.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-204070.9%	0.0%
Net Margin (TTM)	-190220.9%	0.0%
FCF Margin (TTM)	-153231.0%	N/A
Net Income (TTM)	$-301M	$-254M
FCF (TTM)	$-242M	$-228M
EPS (TTM)	-$3.86	-$2.25
ROE (TTM)	-5235.0%	-5056.0%
ROA (TTM)	-4761.0%	-4693.0%
ROIC (TTM)	-5235.0%	-5056.0%
Financial Health
Cash	$47M	$218M
Debt	$0	$0
Net Cash/Debt	$47M	$218M
Current Ratio (TTM)	11.82x	15.08x
Quick Ratio (TTM)	11.71x	14.56x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	2.65
52W Performance	9.7%	39.5%
YTD Performance	10.7%	-6.1%
% from 52W High	-33.8%	-35.0%
% from 52W Low	35.2%	44.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-10.3%	-10.3%
Earnings Yield (TTM)	-12.8%	-11.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-153,328.3	-100.0
EV/GP/RG	42.93	N/A
Ticker research	View CLDX research	View IMNM research